Comments

Corbus Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Corbus Pharmaceuticals (CRBP) operate in?

Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CRBPNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Corbus Pharmaceuticals (CRBP) Forecast

News Earnings Corbus Pharmaceuticals (CRBP) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Corbus Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:CRBP | Benzinga

Explore Corbus Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRBP.

Open	$8.28
Close	-
Volume / Avg.	48.70K / 163.81K
Day Range	$8.10 - $8.47
52 Wk Range	4.64 - 61.90
Market Cap	$100.95M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	18.65%
Days to Cover	16.48

Recent News

Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate

Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

Vandana Singh

Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now

Corbus Pharmaceuticals received buy ratings from H.C. Wainwright and Oppenheimer, citing the company's diversified pipeline.

Nicolás Jose Rodriguez

Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players

Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose. However, investors reacted to limited gains at higher doses. Corbus Pharmaceuticals and Skye Bioscience stocks dropped as all three companies explore CB1 inhibition in obesity treatment.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.28
Close	-
Volume / Avg.	48.70K / 163.81K
Day Range	$8.10 - $8.47
52 Wk Range	4.64 - 61.90
Market Cap	$100.95M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	18.65%
Days to Cover	16.48

About Corbus Pharmaceuticals Holdings Inc

Sector

Health Care

Industry

Biotechnology

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Corbus Pharmaceuticals (CRBP) stock?

You can purchase shares of Corbus Pharmaceuticals (NASDAQ:CRBP) through any online brokerage.

View our list of the best stock brokerages

Who are Corbus Pharmaceuticals (CRBP) competitors?

Other companies in Corbus Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Zentalis Pharma (NASDAQ:ZNTL), Atossa Therapeutics (NASDAQ:ATOS), Citius Oncology (NASDAQ:CTOR) and Whitehawk Therapeutics (NASDAQ:WHWK).

What is the forecast, or price target, for Corbus Pharmaceuticals (CRBP) stock?

Corbus Pharmaceuticals has a consensus price target of $53.56.

What is the current price for Corbus Pharmaceuticals (CRBP)?

The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $8.25 last updated June 18, 2025 at 3:11 PM EDT.

Does Corbus Pharmaceuticals (CRBP) pay a dividend?

There are no upcoming dividends for Corbus Pharmaceuticals.

When is Corbus Pharmaceuticals (NASDAQ:CRBP) reporting earnings?

Corbus Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 5, 2025.

Is Corbus Pharmaceuticals (CRBP) going to split?

There is no upcoming split for Corbus Pharmaceuticals.

What sector and industry does Corbus Pharmaceuticals (CRBP) operate in?

Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.